TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $184,000 | +0.5% | 10,068 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $183,000 | +1.7% | 10,068 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $180,000 | -0.6% | 10,068 | 0.0% | 0.01% | -30.0% |
| Q2 2020 | $181,000 | +18.3% | 10,068 | 0.0% | 0.01% | -9.1% |
| Q1 2020 | $153,000 | -23.5% | 10,068 | -0.6% | 0.01% | 0.0% |
| Q4 2019 | $200,000 | -74.6% | 10,133 | -77.8% | 0.01% | -76.1% |
| Q3 2019 | $787,000 | -2.7% | 45,733 | 0.0% | 0.05% | -2.1% |
| Q2 2019 | $809,000 | -98.2% | 45,733 | +4807.0% | 0.05% | -73.9% |
| Q1 2019 | $45,733,000 | – | 932 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |